CISION PR Newswire: “PLT Granted New, Expanded License for Slendacor® from Health Canada”

Published on February 17, 2021

Share

Share on LinkedIn
Share on Facebook
Share on Twitter
Share via Email

The products and statements made on this web site have not been evaluated by the United States Food and Drug Administration.
These products are not intended to diagnose, treat, cure or prevent disease. This website is for informational purposes only.

Privacy Policy
Terms & Conditions